L-asparaginase

Form: IV Infusion and IV/ IM Injection

Strength: 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion)

Reference Brands: Elspar® , Asparlas®, Erwinase® (US & EU)

Category: Oncology Cancer Care

L-asparaginase is an essential enzyme-based chemotherapy used in the treatment of acute lymphoblastic leukemia (ALL) and lymphomas. It works by depleting asparagine, an amino acid needed for cancer cell survival. Available under brands like Elspar®, Asparlas®, and Erwinase®, it is offered in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via intravenous (IV) or intramuscular (IM) injection, L-asparaginase is widely sourced by B2B pharmaceutical wholesalers in the US and EU. These therapies ensure reliable GMP-compliant distribution for oncology centers, offering competitive pricing and consistent supply for cancer treatment.